English
Insider transactions
EDGARIO Biotech, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
This issuer has insider filings in the store, but no transaction in this window or code group.
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
| Reporting owner | Security | Shares owned after | Direct or indirect | Source |
|---|---|---|---|---|
| Ahmad Qasim Iftikhar Officer: Chief Medical Officer | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 215,000 | D | As of 2025-04-02 Open filing 4 |
| Ahmad Qasim Iftikhar Officer: Chief Medical Officer | Common Stock | 31,350 | D | As of 2024-12-23 Open filing 4 |
| Burkavage Brian Officer: Chief Accounting Officer | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 65,000 | D | As of 2025-04-02 Open filing 4 |
| Collins Helen Louise Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Elling Christian E Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Glaub Kathleen Sereda Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Hirth Peter Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Hunter Heidi Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Hunter Heidi Director | Common Stock | 15,000 | D | As of 2025-05-30 Open filing 4 |
| Smith David V Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 35,144 | D | As of 2025-06-05 Open filing 4 |
| Smith Devin Whittemore Officer: General Counsel | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 140,000 | D | As of 2025-04-02 Open filing 4 |
| Smith Devin Whittemore Officer: General Counsel | Common Stock | 16,938 | D | As of 2024-12-23 Open filing 4 |
| Sullivan Amy Officer: Chief Financial Officer | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 215,000 | D | As of 2025-04-02 Open filing 4 |
| Sullivan Amy Officer: Chief Financial Officer | Common Stock | 84,632 | D | As of 2024-12-23 Open filing 4 |
| Zocca Mai-Britt Director · Officer: Chief Executive Officer | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 580,000 | D | As of 2025-04-02 Open filing 4 |
| Zocca Mai-Britt Director · Officer: Chief Executive Officer | Common Stock | 26,580 | I Zocca Consulting ApS | As of 2024-12-23 Open filing 4 |
| Zocca Mai-Britt Director · Officer: Chief Executive Officer | Common Stock | 49,891 | D | As of 2024-12-23 Open filing 4 |
Joint filers each report the same shares, so rows are not added together.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Institutional ownership reported on Form 13F
No percent is shown: the cover-page share count is not available for this company.
- The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
- Neither includes holders that do not file Form 13F, or managers below the filing threshold.
| Quarter | Managers holding | Shares, at least | Shares, at most | Filings read |
|---|---|---|---|---|
| 2026-09-30 | 0 | 0 | 0 | 8,935 |
| 2026-06-30 | 0 | 0 | 0 | 9,178 |
| 2026-03-31 | 12 | 1,971,675 | 3,391,581 | 9,173 |
| 2025-12-31 | 22 | 5,196,861 | 7,848,183 | 9,222 |
| 2025-09-30 | 21 | 5,576,444 | 9,895,875 | 8,469 |
| 2025-06-30 | 27 | 10,272,240 | 18,182,707 | 8,516 |
| 2025-03-31 | 23 | 10,572,004 | 19,111,617 | 8,518 |
| 2024-12-31 | 28 | 10,765,588 | 19,737,862 | 8,580 |
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share | 3.3 | 2,433,943.00 | 04/02/2026 Filed 2026-04-06 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-26-039923 Dispute this row |
| Lundbeckfond Invest A/S Common Stock, par value $0.001 per share | 27.4 | 21,851,920.00 | 03/31/2026 Filed 2026-06-02 | SCHEDULE 13D/AAmendment 2 | Open filing 0001591046-26-000008 Dispute this row |
| Chernett Jorey Common Stock, $0.001 Par Value Per Share | 0 | 0.00 | 03/31/2026 Filed 2026-05-20 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-001459 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003515 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003515 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003515 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.001 per share | 5.6 | 4,027,112.00 | 02/05/2026 Filed 2026-02-06 | SCHEDULE 13G | Open filing 0000902664-26-000777 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share | 5.6 | 4,027,112.00 | 02/05/2026 Filed 2026-02-06 | SCHEDULE 13G | Open filing 0000902664-26-000777 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.001 per share | 5.6 | 4,027,112.00 | 02/05/2026 Filed 2026-02-06 | SCHEDULE 13G | Open filing 0000902664-26-000777 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.001 per share | 3.3 | 2,469,135.00 | 01/21/2026 Filed 2026-01-23 | SCHEDULE 13D/AAmendment 8 | Open filing 0001388325-26-000003 Dispute this row |
| Chernett Jorey Common | 6.3 | 4,543,532.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0002042077-26-000015 Dispute this row |
| Chernett Jorey Common | 5.3 | 3,477,162.00 | 10/30/2025 Filed 2025-11-05 | SCHEDULE 13G | Open filing 0002042077-25-000006 Dispute this row |
| Vivo Capital IX, LLC Common stock, par value $0.001 per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-25-111138 Dispute this row |
| Vivo Capital Fund IX, L.P. Common stock, par value $0.001 per share | 0 | 0.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-25-111138 Dispute this row |
| Vivo Opportunity, LLC Common stock, par value $0.001 per share | 4.6 | 3,157,894.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-25-111138 Dispute this row |
| Vivo Opportunity Fund Holdings, L.P. Common stock, par value $0.001 per share | 4.6 | 3,157,894.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-25-111138 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.001 per share | 7.3 | 4,981,588.00 | 08/11/2025 Filed 2025-08-19 | SCHEDULE 13D/AAmendment 7 | Open filing 0001415889-25-022324 Dispute this row |
| BANK OF AMERICA CORPORATION Common Stock | 2.8 | 1,844,185 | — Filed 2024-02-13 | SC 13G/AAmendment 01Read from the cover page text | Open filing 0000070858-24-000110 Dispute this row |
| Stonepine Capital Management, LLC Common Stock, $0.001 par value per share | 5.4 | 3,641,345 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000935836-24-000138 Dispute this row |
| Stonepine Capital, L.P. Common Stock, $0.001 par value per share | 5.4 | 3,641,345 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000935836-24-000138 Dispute this row |
| Jon M. Plexico Common Stock, $0.001 par value per share | 5.4 | 3,641,345 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000935836-24-000138 Dispute this row |
| Timothy P. Lynch Common Stock, $0.001 par value per share | 5.4 | 3,641,345 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000935836-24-000138 Dispute this row |
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share | 6.0 | 3,944,492 | — Filed 2024-02-13 | SC 13G/AAmendment 3Read from the cover page text | Open filing 0001104659-24-019876 Dispute this row |
| Samsara BioCapital, L.P. Common Stock, $0.001 par value per share | 5.5 | 3,640,015 | — Filed 2023-12-18 | SC 13GRead from the cover page text | Open filing 0001104659-23-126952 Dispute this row |
| Samsara BioCapital GP, LLC Common Stock, $0.001 par value per share | 5.5 | 3,640,015 | — Filed 2023-12-18 | SC 13GRead from the cover page text | Open filing 0001104659-23-126952 Dispute this row |
| Dr. Srinivas Akkaraju Common Stock, $0.001 par value per share | 5.5 | 3,640,015 | — Filed 2023-12-18 | SC 13GRead from the cover page text | Open filing 0001104659-23-126952 Dispute this row |
| Kurma Partners Common Stock, $0.001 par value per share | 17.18 | 12,253,230 | — Filed 2023-09-07 | SC 13GRead from the cover page text | Open filing 0001140361-23-043145 Dispute this row |
| Stonepine Capital Management, LLC Common Stock, $0.001 par value per share | 5.8 | 3,950,616 | — Filed 2023-08-16 | SC 13GRead from the cover page text | Open filing 0000935836-23-000590 Dispute this row |
| Stonepine Capital, L.P. Common Stock, $0.001 par value per share | 5.8 | 3,950,616 | — Filed 2023-08-16 | SC 13GRead from the cover page text | Open filing 0000935836-23-000590 Dispute this row |
| Jon M. Plexico Common Stock, $0.001 par value per share | 5.8 | 3,950,616 | — Filed 2023-08-16 | SC 13GRead from the cover page text | Open filing 0000935836-23-000590 Dispute this row |
| Timothy P. Lynch Common Stock, $0.001 par value per share | 5.8 | 3,950,616 | — Filed 2023-08-16 | SC 13GRead from the cover page text | Open filing 0000935836-23-000590 Dispute this row |
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share | 8.19 | 5,523,439 | — Filed 2023-08-15 | SC 13G/AAmendment 2Read from the cover page text | Open filing 0001140361-23-039880 Dispute this row |
| Lundbeckfond Invest A/S Common Stock, par value $0.001 per share | 29.6 | 21,851,920 | — Filed 2023-08-14 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001140361-23-039639 Dispute this row |
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share | 6.1 | 3,999,431 | — Filed 2023-08-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001140361-23-039640 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.001 per share | 12.0 | 8,216,202 | — Filed 2023-08-11 | SC 13D/AAmendment 3Read from the cover page text | Open filing 0001193125-23-210822 Dispute this row |
| BANK OF AMERICA CORPORATION Common Stock | 6.4 | 1,854,185 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0000070858-23-000065 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.001 per share | 3.9 | 1,127,260 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001104659-23-021806 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.001 per share | 3.9 | 1,127,260 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001104659-23-021806 Dispute this row |
| Rajeev Shah Common Stock, par value $0.001 per share | 3.9 | 1,127,260 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001104659-23-021806 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.001 per share | 3.4 | 994,265 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001104659-23-021806 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.001 per share | 11.4 | 3,277,932 | — Filed 2022-09-30 | SC 13D/AAmendment 2Read from the cover page text | Open filing 0001193125-22-255654 Dispute this row |
| Novo Holdings A/S Common Stock, par value $0.0001 per share | 11.3 | 3,277,932 | — Filed 2022-05-26 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-22-160579 Dispute this row |
| HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share | 8.4 | 2,420,484 | — Filed 2022-02-11 | SC 13GRead from the cover page text | Open filing 0001104659-22-020452 Dispute this row |
| Avoro Capital Advisors LLC Common Stock, par value $0.001 per share | 7.1 | 2,055,883 | — Filed 2022-02-11 | SC 13GRead from the cover page text | Open filing 0000902664-22-001522 Dispute this row |
| Behzad Aghazadeh Common Stock, par value $0.001 per share | 7.1 | 2,055,883 | — Filed 2022-02-11 | SC 13GRead from the cover page text | Open filing 0000902664-22-001522 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.001 per share | 6.4 | 1,857,755 | — Filed 2021-11-19 | SC 13GRead from the cover page text | Open filing 0001104659-21-141912 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.001 per share | 6.4 | 1,857,755 | — Filed 2021-11-19 | SC 13GRead from the cover page text | Open filing 0001104659-21-141912 Dispute this row |
| Rajeev Shah Common Stock, par value $0.001 per share | 6.4 | 1,857,755 | — Filed 2021-11-19 | SC 13GRead from the cover page text | Open filing 0001104659-21-141912 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.001 per share | 5.7 | 1,641,972 | — Filed 2021-11-19 | SC 13GRead from the cover page text | Open filing 0001104659-21-141912 Dispute this row |
| Lundbeckfond Invest A/S Common Stock, par value $0.001 per share | 21.8 | 6,049,452 | — Filed 2021-11-19 | SC 13DRead from the cover page text | Open filing 0001140361-21-038709 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 246,723 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.